NAD+ injection side effects
NAD+ injections are generally well tolerated when physician-monitored. Here are the common, mild effects and when to check in.
Quick answer
NAD+ is generally considered well tolerated when it is prescribed and monitored by a physician, but no medication is risk-free. The most commonly reported effects are mild and temporary, things like flushing, mild nausea, or brief discomfort at the injection site. NAD+ is a compounded, physician-prescribed medication and is not appropriate for everyone, which is why a physician screens your health history before prescribing and follows your plan over time. In an emergency, call 911. Individual results vary, and NAD+ may support general wellness goals rather than treat any specific condition.
Is NAD+ safe?
There is no honest one-word answer to "is NAD+ safe," because no medication is completely without risk. The fair, evidence-aware way to say it is: NAD+ is generally well tolerated for many people when it is prescribed and monitored by a physician. Safety is not a property of the molecule alone, it comes from the process around it: a physician reviewing whether NAD+ is appropriate for you, prescribing a compounded medication through a licensed pharmacy, starting conservatively, and adjusting based on how you respond.
That is the core reason Kesbury Health's NAD+ is physician-directed rather than something you buy and self-manage. The oversight is the safety mechanism. Much of the strongest NAD+ research is still preclinical or early-stage [1][3], NAD+ is not a treatment for any named disease, and outcomes differ from person to person, so a measured, monitored approach is the responsible one.
What are the most commonly reported side effects?
Across reports, the effects people most often mention with NAD+ are generally mild and transient. Commonly reported, generally mild effects include:
- Flushing, a warm or reddened sensation, often passing within minutes.
- Mild nausea, usually brief and self-limited.
- Temporary discomfort at the injection site, minor tenderness or stinging that typically settles on its own.
- A sensation of pressure or a "rushing" feeling, most associated with administration that happens too quickly (see the next section).
These are reported tendencies, not a prediction of what you personally will experience. Some people notice none of them. Anything that is severe, persistent, or worrying is a reason to contact your care team, and, for an emergency, to call 911.
Why the speed of administration matters
One factual point worth understanding: with rapid intravenous administration in drip clinics, going too fast is a common cause of the transient discomfort people describe, flushing, chest pressure, or a rushing sensation. Slowing the pace generally reduces it.
This is part of why Kesbury Health uses the subcutaneous (SubQ) route, a small shot into the fatty tissue under the skin, rather than an in-clinic intravenous drip. Delivering NAD+ into subcutaneous tissue is a gentler, slower route into the body than a fast intravenous line, which many people find more comfortable. It is a practical difference in delivery, not a claim that one route changes the underlying result.
Who NAD+ may not be appropriate for
NAD+ is not appropriate for everyone, and deciding that is a clinical judgment, not a self-assessment. During the assessment, a licensed Kesbury Health physician reviews your health history, current medications, and goals to determine whether NAD+ is a reasonable fit for you. People with certain health conditions, those who are pregnant or breastfeeding, or anyone whose history raises a concern may be advised against it or directed to a different approach. The honest framing is simple: NAD+ may be appropriate for some people and not for others, and that determination belongs with your physician.
Why physician oversight and monitoring matter
The difference between buying an injectable online and a physician-directed plan shows up exactly here. With ongoing oversight, the same Kesbury Health care team can start conservatively, check in on how you are tolerating the plan, adjust it, order follow-up labs when appropriate, and respond if something does not feel right. That continuity is what makes "generally well tolerated when physician-monitored" an accurate statement rather than a marketing line. Unmonitored use removes the very safeguard that makes the experience safer. In an emergency, call 911.
Frequently asked questions
Is NAD+ injection safe?
NAD+ is generally considered well tolerated for many people when it is prescribed and monitored by a physician, but no medication is risk-free. It is a compounded, physician-prescribed medication and is not appropriate for everyone, which is why a physician screens your history first and follows your plan over time. Individual results vary.
What are the side effects of NAD+ injections?
The most commonly reported effects are mild and temporary, flushing, mild nausea, and brief discomfort at the injection site. A rushing or pressure sensation is most associated with administration that happens too quickly. Severe, persistent, or worrying symptoms are a reason to contact your care team, and an emergency is a reason to call 911.
Why are subcutaneous NAD+ injections gentler than an intravenous drip?
With rapid intravenous administration in drip clinics, going too fast is a common cause of transient discomfort like flushing or a rushing sensation. A subcutaneous shot delivers NAD+ into the fatty tissue under the skin at a slower, gentler pace, which many people find more comfortable. It is a difference in delivery, not a different result.
Who should not take NAD+?
NAD+ is not appropriate for everyone. People with certain health conditions, those who are pregnant or breastfeeding, and anyone whose history raises a concern may be advised against it. A licensed physician makes that determination during the assessment, it is not a self-diagnosis.
Is NAD+ therapy legal?
NAD+ is a compounded medication that licensed physicians may prescribe after an appropriate evaluation. Kesbury Health is LegitScript certified (#51875982), which verifies that prescribing practices meet applicable legal and safety standards. NAD+ should always be used under physician supervision.
Want a physician to review whether NAD+ is right for you?
Start the Kesbury Health evaluation. A licensed physician reviews your goals, health history, and any concerns, and if NAD+ is clinically appropriate, your personalized, physician-directed and monitored plan ships to your door.
Kesbury Health is a LegitScript-certified telehealth longevity practice. NAD+ is a compounded medication prescribed only after physician review. This page is educational and is not individualized medical advice. Individual results vary.
What the published evidence shows
In published human trials of oral NAD+ precursors, side effects were mild and no more frequent than placebo. Those trials tested oral precursors, not injected NAD+, so the safety record for a subcutaneous protocol rests on physician screening and monitoring rather than on trial data.
The largest safety signal in the literature is a 2019 randomized, double-blind, placebo-controlled trial of nicotinamide riboside in healthy overweight adults over 8 weeks. It reported no flushing and no significant difference in adverse events between the treated and placebo groups, or between dose levels, and no elevation of LDL cholesterol. A 2 x 6-week randomized crossover trial in healthy middle-aged and older adults likewise reported it was well tolerated.
Read that carefully, because the gap matters more than the reassurance. Those participants swallowed a precursor. NAD+ given by subcutaneous injection is a different molecule by a different route, and it does not inherit their safety data. What it has instead is a physician who reviews your history, contraindications and current medications before anything is prescribed, and who can stop or change the protocol on what you report.
The effects patients most often describe are mild and short-lived: flushing, brief nausea, or discomfort at the injection site. This is not a complete list of risks. Your physician reviews the ones specific to you. Individual results vary.
References (primary sources)
Every reference below was resolved and checked against its PubMed record on 2026-09-02. Links open the abstract. One title below carries a bracketed elision: the published title names a commercial supplement brand, and reproducing a brand name in our own published copy is what rule N-001 exists to prevent, so the brand is removed and the generic compound name kept. The verbatim title is one click away at the PMID link. Note what these studies are and are not: the human trials listed here tested oral NAD+ precursors (nicotinamide riboside and nicotinamide mononucleotide), not injected NAD+. They are cited for what they establish about NAD+ biology and precursor safety, not as evidence about a subcutaneous protocol.
- Conze D, Brenner C, Kruger CL. Safety and metabolism of long-term administration of [brand name elided] nicotinamide riboside chloride in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Scientific Reports. 2019;9(1):9772. doi:10.1038/s41598-019-46120-z. PMID 31278280.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9(1):1286. doi:10.1038/s41467-018-03421-7. PMID 29599478.
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports. 2019;28(7):1717-1728.e6. doi:10.1016/j.celrep.2019.07.043. PMID 31412242.
- Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metabolism. 2018;27(3):529-547. doi:10.1016/j.cmet.2018.02.011. PMID 29514064.
- Covarrubias AJ, Perrone R, Grozio A, Verdin E. NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. 2021;22(2):119-141. doi:10.1038/s41580-020-00313-x. PMID 33353981.
Keep reading